Literature DB >> 20856768

Increased use of oral chemotherapy drugs spurs increased attention to patient compliance.

.   

Abstract

Ensuring that patients with breast cancer are taking the oral aromatase inhibitors prescribed as follow-up treatment to surgery is an ongoing concern for oncologists.

Entities:  

Year:  2008        PMID： 20856768      PMCID： PMC2793947          DOI： 10.1200/JOP.0843002

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


  2 in total

Review 1.  NCCN Task Force Report: Oral chemotherapy.

Authors:  Saul N Weingart; Elizabeth Brown; Peter B Bach; Kirby Eng; Shirley A Johnson; Timothy M Kuzel; Terry S Langbaum; R Donald Leedy; Raymond J Muller; Lee N Newcomer; Susan O'Brien; Denise Reinke; Mark Rubino; Leonard Saltz; Ronald S Walters
Journal:  J Natl Compr Canc Netw       Date:  2008-03       Impact factor: 11.908

Review 2.  Adherence to therapy with oral antineoplastic agents.

Authors:  Ann H Partridge; Jerry Avorn; Philip S Wang; Eric P Winer
Journal:  J Natl Cancer Inst       Date:  2002-05-01       Impact factor: 13.506
  2 in total
  3 in total

Review 1.  Using Information Technology in the Assessment and Monitoring of Geriatric Oncology Patients.

Authors:  Kah Poh Loh; Colin McHugh; Supriya G Mohile; Karen Mustian; Marie Flannery; Heidi Klepin; Rebecca Schnall; Eva Culakova; Erika Ramsdale
Journal:  Curr Oncol Rep       Date:  2018-03-06       Impact factor: 5.075

2.  High Initiation of Adjuvant Hormonal Therapy Among Uninsured Stages I-III Breast Cancer Patients Treated in a Safety-Net Healthcare System.

Authors:  Caitlin C Murphy; Jasmin A Tiro; Gary W Jean; Bijal A Balasubramian; Carlos A Alvarez
Journal:  J Womens Health (Larchmt)       Date:  2017-03-15       Impact factor: 2.681

3.  Practical strategies to manage cancer patients during the COVID-19 pandemic: Saudi Oncology Pharmacy Assembly Experts recommendations.

Authors:  Majed Alshamrani; Atika AlHarbi; Nora Alkhudair; Fouad AlNajjar; Mansoor Khan; Abdulaziz Ben Obaid; Amr Khardaly; Eshtyag Bajnaid; Hadeel Samarkandi; Aeshah AlAzmi; Salman Alabdali; Mohammed AlNahedh
Journal:  J Oncol Pharm Pract       Date:  2020-06-24       Impact factor: 1.809
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.